These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16244541)
1. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541 [TBL] [Abstract][Full Text] [Related]
2. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH; Kim J; Kahng H; Choi EC Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma. Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016 [TBL] [Abstract][Full Text] [Related]
4. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631 [TBL] [Abstract][Full Text] [Related]
5. Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma. Huang B; Deng S; Loo SY; Datta A; Yap YL; Yan B; Ooi CH; Dinh TD; Zhuo J; Tochhawng L; Gopinadhan S; Jegadeesan T; Tan P; Salto-Tellez M; Yong WP; Soong R; Yeoh KG; Goh YC; Lobie PE; Yang H; Kumar AP; Maciver SK; So JB; Yap CT Oncotarget; 2016 May; 7(18):25391-407. PubMed ID: 27058427 [TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma. Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933 [TBL] [Abstract][Full Text] [Related]
7. Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer. Tannapfel A; Wittekind C; Tahara E Z Gastroenterol; 1994 Feb; 32(2):91-3. PubMed ID: 8165832 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073 [TBL] [Abstract][Full Text] [Related]
9. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032 [TBL] [Abstract][Full Text] [Related]
10. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Davies G; Jiang WG; Mason MD Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727 [TBL] [Abstract][Full Text] [Related]
11. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer. Ahn SY; Kim J; Kim MA; Choi J; Kim WH Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression. Noguchi E; Saito N; Kobayashi M; Kameoka S Mol Med Rep; 2015 May; 11(5):3423-31. PubMed ID: 25592281 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1. Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209 [TBL] [Abstract][Full Text] [Related]
14. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof]. Ru GQ; Zhao ZS; Tang QL; Xu WJ Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530 [TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma]. Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699 [TBL] [Abstract][Full Text] [Related]
17. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer. Murakami N; Koufuji K; Shirouzu K Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071 [TBL] [Abstract][Full Text] [Related]
18. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer. Lee JC; Koh SA; Lee KH; Kim JR Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177 [TBL] [Abstract][Full Text] [Related]
19. Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer. Li S; Zhang H; Wang X; Qu Y; Duan J; Liu R; Deng T; Ning T; Zhang L; Bai M; Zhou L; Wang X; Ge S; Ying G; Ba Y Tumour Biol; 2016 Nov; 37(11):15175-15183. PubMed ID: 27683052 [TBL] [Abstract][Full Text] [Related]
20. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value. Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T J BUON; 2017; 22(2):383-389. PubMed ID: 28534359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]